Lv41
520 积分 2025-01-17 加入
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
49分钟前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
2小时前
已完结
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
3小时前
已完结
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)
2天前
已完结
Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989
2天前
已完结
皖公网安备34019202002308
